AzurRx BioPharma, Inc.
AzurRx BioPharma, Inc. (AZRX) Stock Overview
Explore AzurRx BioPharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.4M
P/E Ratio
-0.58
EPS (TTM)
$-1.87
ROE
-33.06%
AZRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of AzurRx BioPharma, Inc. (AZRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $9.70.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.58 and a market capitalization of 3.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.